Page last updated: 2024-09-04

levofloxacin and Infections, Legionella pneumophila

levofloxacin has been researched along with Infections, Legionella pneumophila in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (11.11)	18.2507
2000's	14 (38.89)	29.6817
2010's	15 (41.67)	24.3611
2020's	3 (8.33)	2.80

Authors

Authors	Studies
Chasqueira, MJ; Cruz, C; Fernandes, F; Paixão, P; Rodrigues, L; Santos, R	1
Bell, K; Kaloti, Z; Khalid, M; Levine, D	1
Bartoli, TA; Bevilacqua, N; D'Abramo, A; Di Rosa, E; Giancola, ML; Lepore, L; Maffongelli, G; Mariano, A; Nicastri, E; Palazzolo, C; Vulcano, A	1
Cardoso, L; Gonçalves, JR; Marques, R; Serra, P	1
Kazi, S; Preston, GC	1
Atic, A; Basic-Jukic, N; Kirincich, J; Sakic, Z	1
Chaudhry, R; Sreenath, K; Thakur, B; Vinayaraj, EV	1
Chongnarungsin, D; Edmonds, LC; Srivali, N; Ungprasert, P	1
Aubart, K; Butler, D; Dubois, J; Dubois, M; Martel, JF	1
Sivasambu, B; Yogarajah, M	1
Armesto, A; Calviño, J; Cigarrán, S; Coronel, D	1
Burgos, J; Carratalà, J; Falco, V; Garcia-Vidal, C; Martin, MT; Sanchez-Rodriguez, I; Simonetti, AF; Viasus, D	1
Carratalà, J; Garcia-Vidal, C	1
Fujikawa, K; Karibe, Y; Kashimoto, Y; Kurosaka, Y; Namba, K; Otani, T; Uoyama, S; Yamaguchi, K	1
Arnold, F; Griffin, AT; Peyrani, P; Wiemken, T	1
Baddour, LM; Edelstein, PH; Han, JH; Harada, S; Nguyen, JC	1
Rókusz, L	1
Ishii, Y; Kimura, S; Sato, T; Tateda, K; Yamaguchi, K	1
Drokov, MIu; Galstian, GM; Giliazitdinova, EA; Karpova, TI; Katrysh, SA; Kliasova, GA; Marakusha, BI; Tartakovskiĭ, IS	1
Arakaki, N; Higa, F; Kawakami, K; Koide, M; Saito, A; Shinzato, T; Tateyama, M	1
Dunbar, LM; Kahn, JB; Khashab, MM; Tennenberg, AM; Xiang, JX; Zadeikis, N	1
Greenberg, RN; Khashab, MM; Olson, WH; Stout, JE; Tennenberg, AM; Yu, VL; Zadeikis, N	1
Carratalà, J; Dorca, J; Fernández-Sabé, N; Gudiol, F; Manresa, F; Mykietiuk, A; Verdaguer, R	1
Alemany Francés, L; Blázquez Garrido, RM; Espinosa Parra, FJ; Huerta, FH; Ramos Guevara, RM; Sánchez-Nieto, JM; Segovia Hernández, M; Serrano Martínez, JA	1
Kraus, CN; Powers, JH; Zalkikar, J	1
Lück, PC; Steinert, M	1
Pedro-Botet, L; Yu, VL	1
García-Cruz, A; Mateu, L; Pedro-Botet, ML; Rey-Joly, C; Roure, S; Sabria, M; Sopena, N; Tural, C	1
Angeles Domínguez, M; Carratalà, J; Fernández-Sevilla, A; Gudiol, C; Verdaguer, R	1
Baltch, AL; Ritz, W; Smith, RP	1
Edelstein, MA; Edelstein, PH; Lehr, KH; Ren, J	1
Takazakura, E; Tsuji, H	1
Arnold, B; Stout, JE; Yu, VL	1
Hatakeyama, S; Oka, T; Suzuki, K; Tachibana, A; Tateda, K; Yamaguchi, K	1
Baltch, AL; Franke, MA; Michelsen, PB; Ritz, WJ; Smith, RP	1
Doyle, E; Edelstein, MA; Edelstein, PH; Shinzato, T	1

Reviews

4 review(s) available for levofloxacin and Infections, Legionella pneumophila

Article	Year
An update on Legionella. Current opinion in infectious diseases, 2010, Volume: 23, Issue:2 Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Community-Acquired Infections; Cross Infection; Germany; Humans; Incidence; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Ofloxacin; United States	2010
Relapsing Legionella pneumophila cellulitis: a case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2010, Volume: 16, Issue:6 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Cellulitis; Fatal Outcome; Female; Humans; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Ofloxacin; Recurrence	2010
[Pathogenesis, diagnosis and therapy of Legionella infections]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2006, Volume: 49, Issue:5 Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Aza Compounds; Azithromycin; Ciprofloxacin; Diagnosis, Differential; DNA, Bacterial; Fluoroquinolones; Humans; Incidence; Legionella; Legionella pneumophila; Legionellosis; Legionnaires' Disease; Levofloxacin; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Serotyping; Virulence	2006
Legionella: macrolides or quinolones? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12 Suppl 3 Topics: Animals; Anti-Infective Agents; Azithromycin; Clinical Trials as Topic; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones	2006

Trials

3 trial(s) available for levofloxacin and Infections, Legionella pneumophila

Article	Year
Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens. Current medical research and opinion, 2004, Volume: 20, Issue:4 Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Mycoplasma	2004
Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Mar-15, Volume: 40, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Female; Humans; Legionnaires' Disease; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Time Factors	2005
Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Mar-15, Volume: 40, Issue:6 Topics: Anti-Bacterial Agents; Case-Control Studies; Disease Outbreaks; Drug Therapy, Combination; Female; Humans; Legionnaires' Disease; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Rifampin	2005

Other Studies

29 other study(ies) available for levofloxacin and Infections, Legionella pneumophila

Article	Year
Antibiotic susceptibility pattern of Portuguese environmental Legionella isolates. Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Doxycycline; Fluoroquinolones; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Portugal	2023
Cerebellar ataxia a unique initial presentation of Legionnaires' disease. BMJ case reports, 2020, Mar-10, Volume: 13, Issue:3 Topics: Anti-Bacterial Agents; Cerebellar Ataxia; Gait Disorders, Neurologic; Humans; Legionella; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Tremor	2020
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020, Volume: 25, Issue:30 Topics: Administration, Intravenous; Adult; Anti-Infective Agents, Urinary; Antigens, Bacterial; Cough; Fever; Headache; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Pneumonia; Treatment Outcome	2020
Acute fibrinous and organising pneumonia. BMJ case reports, 2017, Sep-07, Volume: 2017 Topics: Anti-Bacterial Agents; Biopsy; Community-Acquired Infections; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Female; Fever; Fibrin; Glucocorticoids; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Lung; Lung Diseases, Interstitial; Middle Aged; Pneumonia; Prednisolone; Radiography; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome	2017
Drug induced thrombotic microangiopathy caused by levofloxacin. The journal of the Royal College of Physicians of Edinburgh, 2018, Volume: 48, Issue:2 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Thrombotic Microangiopathies	2018
Community Acquired Legionnaire's Disease in a Kidney Transplant Patient. Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2018, Dec-01, Volume: 39, Issue:2-3 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Critical Care; Humans; Immunocompromised Host; Kidney Transplantation; Legionellosis; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia; Radiography, Thoracic; Treatment Outcome	2018
Antibiotic susceptibility of environmental Future microbiology, 2019, Volume: 14 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Environmental Microbiology; Environmental Monitoring; Fluoroquinolones; Humans; India; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Rifampin; Tertiary Care Centers; Tetracycline; Water; Water Microbiology	2019
Two cases of Legionnaires' disease associated with continuous positive airway pressure therapy. Sleep medicine, 2013, Volume: 14, Issue:10 Topics: Anti-Bacterial Agents; Continuous Positive Airway Pressure; Equipment Contamination; Female; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Sleep Apnea, Obstructive	2013
In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Bridged Bicyclo Compounds, Heterocyclic; Humans; Hydroxamic Acids; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests	2015
Legionnaires disease presenting as acute kidney injury in the absence of pneumonia. BMJ case reports, 2015, Feb-17, Volume: 2015 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Diagnosis, Differential; Humans; Legionnaires' Disease; Levofloxacin; Lung; Male; Middle Aged; Pneumonia; Radiography	2015
Legionella Pneumophila: A Renal Vasculitis Trigger? Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:6 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cyclophosphamide; Humans; Immunosuppressive Agents; Kidney Diseases; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Prednisone; Renal Dialysis; Vasculitis	2016
Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:9 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Female; Humans; Legionnaires' Disease; Length of Stay; Levofloxacin; Male; Middle Aged; Propensity Score; Retrospective Studies; Spain; Treatment Outcome	2017
[Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice]. The Japanese journal of antibiotics, 2009, Volume: 62, Issue:5 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Bacterial; Female; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Ofloxacin; Treatment Outcome	2009
Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2010, Volume: 14, Issue:4 Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Female; Humans; Kaplan-Meier Estimate; Legionella pneumophila; Legionnaires' Disease; Length of Stay; Levofloxacin; Male; Ofloxacin; Retrospective Studies; Time Factors; Treatment Outcome	2010
Case of Legionella pneumonia complicated with pulmonary thromboembolism. Acta microbiologica et immunologica Hungarica, 2010, Volume: 57, Issue:4 Topics: Anti-Bacterial Agents; Anticoagulants; Community-Acquired Infections; Heparin; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Ofloxacin; Pulmonary Embolism; Thrombophilia	2010
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged-Ring Compounds; Cell Line; Cells, Cultured; Clarithromycin; Disease Models, Animal; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Mice; Microbial Sensitivity Tests; Ofloxacin	2011
[A case of legionellesis pneumonia verified by isolation of Legionella pneumophila serogroup 1 from bronchoalveolar lavage fluid treated with levofloxacine and tigecycline]. Terapevticheskii arkhiv, 2011, Volume: 83, Issue:7 Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pneumonia, Bacterial; Tigecycline; Treatment Outcome	2011
In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:6 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cell Line; Erythromycin; Fluoroquinolones; Guinea Pigs; Half-Life; Legionella; Legionnaires' Disease; Levofloxacin; Macrophages; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones	2003
Levofloxacin efficacy in the treatment of community-acquired legionellosis. Chest, 2004, Volume: 125, Issue:6 Topics: Clinical Trials as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Ofloxacin; Risk Assessment; Treatment Outcome	2004
Levofloxacin and macrolides for treatment of Legionnaires disease: multiple comparisons give few answers. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Aug-01, Volume: 41, Issue:3 Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Legionnaires' Disease; Levofloxacin; Macrolides; Ofloxacin	2005
Severe Legionnaires' disease successfully treated with levofloxacin and azithromycin. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Legionnaires' Disease; Levofloxacin; Lung; Middle Aged; Ofloxacin; Radiography; Remission Induction	2006
Outbreak of Legionnaires' disease in immunosuppressed patients at a cancer centre: usefulness of universal urine antigen testing and early levofloxacin therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2007, Volume: 13, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antigens, Bacterial; Cancer Care Facilities; Cross Infection; Female; Humans; Immunocompromised Host; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Ofloxacin; Spain	2007
Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Time Factors	1995
In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:1 Topics: Animals; Anti-Infective Agents; Guinea Pigs; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin	1996
[Legionella pneumonia successfully treated despite late diagnosis]. Nihon Kyobu Shikkan Gakkai zasshi, 1997, Volume: 35, Issue:5 Topics: Administration, Oral; Aged; Anti-Infective Agents; Cilastatin; Drug Combinations; Humans; Imipenem; Legionnaires' Disease; Levofloxacin; Male; Ofloxacin; Protease Inhibitors; Thienamycins	1997
Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells. Diagnostic microbiology and infectious disease, 1998, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Erythromycin; HL-60 Cells; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results	1998
[Fibrosing alveolitis following Legionella pneumonia]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2000, Volume: 38, Issue:4 Topics: Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pulmonary Fibrosis; Pulse Therapy, Drug; Steroids; Treatment Outcome	2000
Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:1 Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Monocytes; Ofloxacin	2000
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:8 Topics: Animals; Anti-Infective Agents; Area Under Curve; Azithromycin; Body Weight; Fluoroquinolones; Gemifloxacin; Guinea Pigs; Half-Life; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Lung; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Survival Rate	2001